Is Arrowhead Pharmaceuticals Inc (ARWR) a Good Buy in the Healthcare Sector?

Arrowhead Pharmaceuticals Inc (ARWR) is around the top of the Healthcare sector according to InvestorsObserver. ARWR received an overall rating of 58, which means that it scores higher than 58% of stocks. Additionally, Arrowhead Pharmaceuticals Inc scored a 87 in the Healthcare sector, ranking it higher than 87% of stocks in that sector.

ARWR has an Overall Score of 58. Find out what this means to you and get the rest of the rankings on ARWR!

See Full ARWR Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 58 means the stock is more attractive than 58 percent of stocks. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Arrowhead Pharmaceuticals Inc Stock Today?

Arrowhead Pharmaceuticals Inc (ARWR) stock is trading at $38.20 as of 3:15 PM on Tuesday, Aug 30, a decline of -$1.02, or -2.6% from the previous closing price of $39.22. The stock has traded between $37.42 and $40.20 so far today. Volume today is low. So far 358,181 shares have traded compared to average volume of 706,620 shares. Click Here to get the full Stock Report for Arrowhead Pharmaceuticals Inc stock.